Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.76 is 97% above its 5-year average of 1.90, near the high end of its 5-year range (0.22–3.76).
As of the fiscal period ended Tuesday, June 30, 2026. 205.46% above its 12-month average of 1.23.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.76.
QUICK RATIO (ACID-TEST)
3.76
QUICK RATIO (ACID-TEST) AVG TTM
1.23
QUICK RATIO (ACID-TEST) AVG 3Y
1.80
QUICK RATIO (ACID-TEST) AVG 5Y
1.90
QUICK RATIO (ACID-TEST) AVG 10Y
2.77
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+205.46%
CURRENT VS 3Y AVG
+108.60%
CURRENT VS 5Y AVG
+97.36%
CURRENT VS 10Y AVG
+35.64%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+12.19%
vs the sector median at left
MeiraGTx Holdings plc
Market Cap
$976.80M
Quick Ratio (Acid-Test)
3.76
TTM Avg
1.23
3Y Avg
1.80
5Y Avg
1.90
Market Cap
$981.10M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$978.73M
Quick Ratio (Acid-Test)
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$969.12M
Quick Ratio (Acid-Test)
3.94
TTM Avg
2.64
3Y Avg
3.04
5Y Avg
2.66
Market Cap
$992.10M
Quick Ratio (Acid-Test)
5.35
TTM Avg
6.89
3Y Avg
6.87
5Y Avg
8.97
Market Cap
$992.39M
Quick Ratio (Acid-Test)
19.15
TTM Avg
11.70
3Y Avg
12.62
5Y Avg
12.74
Market Cap
$951.89M
Quick Ratio (Acid-Test)
10.13
TTM Avg
12.79
3Y Avg
15.72
5Y Avg
14.10
Market Cap
$954.07M
Quick Ratio (Acid-Test)
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
Market Cap
$998.69M
Quick Ratio (Acid-Test)
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | $976.80M | 3.76 | 1.23 | 1.80 | 1.90 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $981.10M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $978.73M | 15.08 | 22.50 | 27.08 | 27.08 |
| Pacira BioSciences, Inc. (PCRX)vs › | $969.12M | 3.94 | 2.64 | 3.04 | 2.66 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $992.10M | 5.35 | 6.89 | 6.87 | 8.97 |
| Vor Biopharma Inc. (VOR)vs › | $992.39M | 19.15 | 11.70 | 12.62 | 12.74 |
| Savara Inc. (SVRA)vs › | $951.89M | 10.13 | 12.79 | 15.72 | 14.10 |
| Aktis Oncology, Inc. (AKTS)vs › | $954.07M | 16.33 | 11.68 | 16.13 | 16.13 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $998.69M | 8.42 | 11.89 | 15.48 | 17.00 |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
Quick Ratio
3.76
Excludes inventory
Current Ratio
3.76
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.76 |
| 2026-03-31 | 0.55 |
| 2025-12-31 | 0.75 |
| 2025-09-30 | 0.22 |
| 2025-06-30 | 0.88 |
| 2025-03-31 | 1.51 |
| 2024-12-31 | 2.03 |
| 2024-09-30 | 2.34 |
| 2024-06-30 | 2.36 |
| 2024-03-31 | 3.14 |
| 2023-12-31 | 2.38 |
| 2023-09-30 | 1.52 |
| 2023-06-30 | 1.99 |
| 2023-03-31 | 1.50 |
| 2022-12-31 | 1.78 |
| 2022-09-30 | 2.14 |
| 2022-06-30 | 1.55 |
| 2022-03-31 | 2.18 |
| 2021-12-31 | 2.69 |
| 2021-09-30 | 2.97 |
| 2021-06-30 | 3.62 |
| 2021-03-31 | 4.30 |
| 2020-12-31 | 5.03 |
| 2020-09-30 | 4.67 |
| 2020-06-30 | 5.03 |
| 2020-03-31 | 5.83 |
| 2019-12-31 | 5.47 |
| 2019-09-30 | 6.90 |
| 2019-06-30 | 5.22 |
| 2019-03-31 | 6.96 |
| 2018-12-31 | 4.91 |
| 2018-09-30 | 10.76 |
| 2018-06-30 | 11.84 |
| 2018-03-31 | 3.03 |
| 2017-12-31 | 0.54 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
